Christos Liolios1, George Laros1, Kyriakos Georgiou1

  • 1Laboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens (NKUA), Panepistimiopolis-Zografou, 15771 Athens, Greece.

PubMed
概括

向前列腺特异性膜抗原 (PSMA) 的干向药物 (LTD) 对转移性割耐药前列腺癌显示有前途. 这些针对PSMA的LTD直接向癌细胞输送细胞毒剂,性能优于传统化疗.